APA

Liu C., Liu L., Wang K., Li X., Ge L., Ma R., Fan Y., Li L., Liu Z., Qiu M., Hao Y., Shi Z., Xia C., Strååt K., Huang Y., Ma L. & Xu D. (20201124). VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR. : Oncogene.

Chicago

Liu Cheng, Liu Li, Wang Kun, Li Xiao-Feng, Ge Li-Yuan, Ma Run-Zhuo, Fan Yi-Dong, Li Lu-Chao, Liu Zheng-Fang, Qiu Min, Hao Yi-Chang, Shi Zhen-Feng, Xia Chuan-You, Strååt Klas, Huang Yi, Ma Lu-Lin and Xu Dawei. 20201124. VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR. : Oncogene.

Harvard

Liu C., Liu L., Wang K., Li X., Ge L., Ma R., Fan Y., Li L., Liu Z., Qiu M., Hao Y., Shi Z., Xia C., Strååt K., Huang Y., Ma L. and Xu D. (20201124). VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR. : Oncogene.

MLA

Liu Cheng, Liu Li, Wang Kun, Li Xiao-Feng, Ge Li-Yuan, Ma Run-Zhuo, Fan Yi-Dong, Li Lu-Chao, Liu Zheng-Fang, Qiu Min, Hao Yi-Chang, Shi Zhen-Feng, Xia Chuan-You, Strååt Klas, Huang Yi, Ma Lu-Lin and Xu Dawei. VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR. : Oncogene. 20201124.